The United States peptide hormones market accounts for the largest share of the North American region, supported by high healthcare expenditure, a large patient population affected by hormonal and metabolic disorders, and a robust pharmaceutical industry. Increasing demand for peptide hormone therapies in diabetes management, growth hormone replacement, fertility treatments, and endocrine...